| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Operating Segments-Specialty Chemicals Segment | 2,811 | 3,439 | 5,840 | NaN |
| Corporate Non Segment | 0 | 0 | 0 | NaN |
| Gross profit | 2,811 | 3,439 | 13,773 | NaN |
| Operating Segments-Specialty Chemicals Segment | 63 | 0 | NaN | NaN |
| Corporate Non Segment | 0 | 71 | NaN | NaN |
| Research and development | 63 | 71 | NaN | NaN |
| Selling, general and administrative expense | 4,874 | 5,394 | 17,567 | NaN |
| Depreciation and amortization | 250 | 1,132 | NaN | NaN |
| Acquisition costs and other | NaN | 66 | 665 | NaN |
| Operating Segments-Specialty Chemicals Segment | NaN | 0 | 0 | NaN |
| Corporate Non Segment | NaN | 0 | 0 | NaN |
| Asset impairments | NaN | 0 | 0 | NaN |
| Operating Segments-Specialty Chemicals Segment | NaN | 0 | 0 | NaN |
| Corporate Non Segment | NaN | 1,734 | 0 | NaN |
| Gain on lease modification | NaN | 1,734 | NaN | NaN |
| Interest expense (income), net | 294 | 712 | NaN | NaN |
| Gain on lease modification | NaN | 1,734 | 544 | NaN |
| Interest expense (income), net | NaN | NaN | -347 | NaN |
| Operating Segments-Specialty Chemicals Segment | 0 | NaN | 0 | NaN |
| Corporate Non Segment | 114 | NaN | 57 | NaN |
| Income taxes | 114 | 54 | -32 | NaN |
| Operating Segments-Specialty Chemicals Segment | NaN | NaN | 0 | NaN |
| Corporate Non Segment | NaN | NaN | 296 | NaN |
| Other expense (income) | 216 | 172 | 296 | NaN |
| Net loss from continuing operations | -1,980 | -1,007 | -124 | -4,453 |
| Depreciation expense | 861 | 850 | 854 | 1,870 |
| Amortization expense | 117 | 153 | 153 | 306 |
| Amortization of debt issuance costs | 50 | 41 | 38 | 179 |
| Asset impairments | NaN | 0 | 0 | 1,622 |
| Deferred income taxes | 114 | 54 | 58 | -90 |
| Provision for (reduction of) losses on accounts receivable | 15 | -81 | 18 | -506 |
| Loss on disposal of property, plant and equipment | NaN | -1 | NaN | NaN |
| Non-cash lease expense | -26 | 43 | 86 | -1 |
| Stock-based compensation expense | 157 | 790 | 290 | 222 |
| Accounts receivable and advances | 2,524 | -2,634 | 302 | 4,908 |
| Inventories | -1,312 | 1,565 | 511 | 939 |
| Other assets and liabilities | -121 | -996 | -420 | 1,937 |
| Accounts payable | -1,185 | -30 | 177 | -1,712 |
| Accrued expenses | -2,599 | -272 | 354 | 1,387 |
| Accrued income taxes | 139 | -30 | -138 | 19 |
| Net cash used in operating activities - continuing operations | -5,428 | 299 | 1,373 | -8,941 |
| Net cash provided by operating activities - discontinued operations | 0 | -33 | -62 | 6,845 |
| Net cash used in operating activities | -5,428 | 266 | 1,311 | -2,096 |
| Purchases of property, plant and equipment | 422 | 462 | 616 | 466 |
| Net cash used in investing activities - continuing operations | -422 | -462 | -616 | -466 |
| Net cash used in investing activities - discontinued operations | 0 | 0 | -1,900 | 54,425 |
| Proceeds from note payable | NaN | 0 | 0 | 1,085 |
| Net cash used in investing activities | -422 | -462 | -2,516 | 53,959 |
| Borrowings from credit facilities | 27,150 | 22,605 | 24,800 | 89,670 |
| Proceeds from exercise of stock options | 398 | 415 | NaN | NaN |
| Payments on credit facilities | 27,150 | 22,605 | 24,800 | 89,670 |
| Payments on note payable | 326 | 325 | 326 | 370 |
| Principal payments on finance lease obligations | 81 | 68 | 75 | 144 |
| Repurchase of common stock | 3,926 | 262 | 831 | 8,044 |
| Net cash used in financing activities - continuing operations | -3,935 | -240 | -1,232 | -7,473 |
| Net cash used in financing activities - discontinued operations | 0 | 0 | 0 | -19 |
| Net cash used in financing activities | -3,935 | -240 | -1,232 | -7,492 |
| Decrease in cash and cash equivalents | -9,785 | -436 | -2,437 | 44,371 |
| Cash and cash equivalents of discontinued operations | NaN | 0 | NaN | NaN |
| Cash and cash equivalents at beginning of period | 57,606 | 58,042 | 16,108 | NaN |
| Cash and cash equivalents at end of period | 47,821 | 57,606 | 58,042 | NaN |
ASCENT INDUSTRIES CO. (ACNT)
ASCENT INDUSTRIES CO. (ACNT)